Cargando…
IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma
Insulin-like growth factor 2 (IGF2) overexpression is an important molecular marker of adrenocortical carcinoma (ACC), which is a rare but devastating endocrine cancer. It is not clear whether IGF2 overexpression modifies the biology and growth of this cancer, thus more studies are required before I...
Autores principales: | Guillaud-Bataille, Marine, Ragazzon, Bruno, de Reyniès, Aurélien, Chevalier, Claire, Francillard, Isabelle, Barreau, Olivia, Steunou, Virginie, Guillemot, Johann, Tissier, Frédérique, Rizk-Rabin, Marthe, René-Corail, Fernande, Ghuzlan, Abir Al, Assié, Guillaume, Bertagna, Xavier, Baudin, Eric, Le Bouc, Yves, Bertherat, Jérôme, Clauser, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121173/ https://www.ncbi.nlm.nih.gov/pubmed/25089899 http://dx.doi.org/10.1371/journal.pone.0103744 |
Ejemplares similares
-
Silencing Mutated β-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R
por: Gaujoux, Sébastien, et al.
Publicado: (2013) -
Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma
por: Lefèvre, L, et al.
Publicado: (2015) -
Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinoma
por: Jouinot, Anne, et al.
Publicado: (2022) -
Loco-Regional Therapies in Oligometastatic Adrenocortical Carcinoma
por: Roux, Charles, et al.
Publicado: (2022) -
Adrenocortical Carcinoma
por: Berruti, Alfredo, et al.
Publicado: (2021)